Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 18;54(4):1659-1670.
doi: 10.3233/JAD-160509.

Dual Kinase Inhibition Affords Extended in Vitro Neuroprotection in Amyloid-β Toxicity

Affiliations

Dual Kinase Inhibition Affords Extended in Vitro Neuroprotection in Amyloid-β Toxicity

Sarah Gourmaud et al. J Alzheimers Dis. .

Abstract

In Alzheimer's disease (AD), the amyloid cascade hypothesis proposes that amyloid-beta (Aβ) neurotoxicity leads to neuroinflammation, synaptic loss, and neuronal degeneration. In AD patients, anti-amyloid immunotherapies did not succeed because they were possibly administered late in AD progression. Modulating new targets associated with Aβ toxicity, such as PKR (double-stranded RNA dependent kinase), and JNK (c-Jun N-terminal kinase) is a major goal for neuroprotection. These two pro-apoptotic kinases are activated in AD brains and involved in Aβ production, tau phosphorylation, neuroinflammation, and neuronal death. In HEK cells transfected with siRNA directed against PKR, and in PKR knockout (PKR-/-) mice neurons, we showed that PKR triggers JNK activation. Aβ-induced neuronal apoptosis, measured by cleaved PARP (Poly ADP-ribose polymerase) and cleaved caspase 3 levels, was reduced in PKR-/- neurons. Two selective JNK inhibitory peptides also produced a striking reduction of Aβ toxicity. Finally, the dual inhibition of PKR and JNK nearly abolished Aβ toxicity in primary cultured neurons. These results reveal that dual kinase inhibition can afford neuroprotection and this approach is worth being tested in in vivo AD and oxidative stress models.

Keywords: Alzheimer’s disease; JNK; PKR; amyloid-beta; neuronal death; therapeutic strategy.

Similar articles

See all similar articles

Cited by 3 articles

  • Neuronal Cell Death.
    Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC. Fricker M, et al. Physiol Rev. 2018 Apr 1;98(2):813-880. doi: 10.1152/physrev.00011.2017. Physiol Rev. 2018. PMID: 29488822 Free PMC article. Review.
  • Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT.
    Dabo S, Maillard P, Collados Rodriguez M, Hansen MD, Mazouz S, Bigot DJ, Tible M, Janvier G, Helynck O, Cassonnet P, Jacob Y, Bellalou J, Gatignol A, Patel RC, Hugon J, Munier-Lehmann H, Meurs EF. Dabo S, et al. Sci Rep. 2017 Nov 23;7(1):16129. doi: 10.1038/s41598-017-16089-8. Sci Rep. 2017. PMID: 29170442 Free PMC article.
  • PKR involvement in Alzheimer's disease.
    Hugon J, Mouton-Liger F, Dumurgier J, Paquet C. Hugon J, et al. Alzheimers Res Ther. 2017 Oct 5;9(1):83. doi: 10.1186/s13195-017-0308-0. Alzheimers Res Ther. 2017. PMID: 28982375 Free PMC article. Review.

Publication types

Substances

LinkOut - more resources

Feedback